WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004002548) USE OF ORGANIC COMPOUNDS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/002548    International Application No.:    PCT/EP2003/006847
Publication Date: 08.01.2004 International Filing Date: 27.06.2003
Chapter 2 Demand Filed:    07.01.2004    
IPC:
A61L 27/34 (2006.01), A61L 27/54 (2006.01), A61L 29/08 (2006.01), A61L 29/16 (2006.01), A61L 31/10 (2006.01), A61L 31/16 (2006.01)
Applicants: NOVARTIS AG [CH/CH]; Lichtstasse 35, CH-4056 Basel (CH) (AE, AG, AL, AM, AU, AZ, BA, BB, BE, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CY, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, FR, GB, GD, GE, GH, GR, HR, HU, ID, IE, IL, IN, IS, IT, JP, KE, KG, KP, KR, KZ, LC, LK, LT, LU, LV, MA, MC, MD, MK, MN, MX, NI, NL, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SE, SG, SI, SK, TJ, TM, TN, TR, TT, UA, UZ, VC, VN, YU, ZA, ZW only).
NOVARTIS PHARMA GMBH [AT/AT]; Brunner Stasse 59, A-1230 Vienna (AT) (AE, AG, AL, AM, AU, AZ, BA, BB, BE, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CY, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, FR, GB, GD, GE, GH, GR, HR, HU, ID, IE, IL, IN, IS, IT, JP, KE, KG, KP, KR, KZ, LC, LK, LT, LU, LV, MA, MC, MD, MK, MN, MX, NI, NL, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SE, SG, SI, SK, TJ, TM, TN, TR, TT, UA, US, UZ, VC, VN, YU, ZA, ZW only).
PRESCOTT, Margaret, Forney [US/US]; (US) (For US Only)
Inventors: PRESCOTT, Margaret, Forney; (US)
Agent: GRUBB, Philip; Novartis AG, Corporate Intellectual Property, CH-4002 Basel (CH)
Priority Data:
60/392,587 28.06.2002 US
Title (EN) USE OF ORGANIC COMPOUNDS
(FR) UTILISATION DE COMPOSES ORGANIQUES
Abstract: front page image
(EN)The present invention relates to drug delivery systems, comprising an angiotensin converting enzyme inhibitor (ACE­inhibitor) or a pharmaceutically acceptable salt thereof, for the prevention and treatment of proliferative diseases, particularly vascular diseases. The invention furthermore relates to the use of such drug delivery systems, for preventing or treating restenosis in diabetic and non-diabetic patients, or for the prevention or reduction of vascular access dysfunction in association with the insertion or repair of an indwelling shunt, fistula or catheter in a subject in need thereof.
(FR)L'invention concerne des systèmes de distribution de médicaments comprenant un inhibiteur d'enzyme convertissant une angiotensine (inhibiteur de ACE) ou un sel de celui-ci pharmaceutiquement acceptable qui permet de prévenir et de traiter des maladies prolifératives, en particulier, les maladies vasculaires. L'invention concerne également l'utilisation de ces systèmes de distribution de médicaments pour prévenir ou traiter la resténose chez des patients diabétiques et non diabétiques ou pour prévenir ou réduire un dysfonctionnement d'accès vasculaire ainsi que pour introduire ou réparer une dérivation, une fistule ou un cathéter à demeure chez un sujet qui en a besoin.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LT, LU, LV, MA, MD, MK, MN, MX, NI, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SE, SG, SK, TJ, TM, TN, TR, TT, UA, US, UZ, VC, VN, YU, ZA, ZW.
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR).
Publication Language: English (EN)
Filing Language: English (EN)